Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Accenture
Medtronic
UBS
Colorcon
Deloitte
Baxter
Johnson and Johnson
Mallinckrodt
McKinsey

Generated: February 18, 2018

DrugPatentWatch Database Preview

ENTECAVIR Drug Profile

« Back to Dashboard

When do Entecavir patents expire, and when can generic versions of Entecavir launch?

Entecavir is a drug marketed by Accord Hlthcare, Amneal Pharms, Aurobindo Pharma Ltd, Cipla Ltd, Hetero Labs Ltd V, Par Pharm Inc, Prinston Inc, Sandoz Inc, Teva Pharms Usa, and Zydus Pharms Usa Inc. and is included in ten NDAs.

The generic ingredient in ENTECAVIR is entecavir. There are sixteen drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the entecavir profile page.

US Patents and Regulatory Information for ENTECAVIR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Accord Hlthcare ENTECAVIR entecavir TABLET;ORAL 205824-001 Aug 25, 2017 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Teva Pharms Usa ENTECAVIR entecavir TABLET;ORAL 202122-002 Aug 26, 2014 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Cipla Ltd ENTECAVIR entecavir TABLET;ORAL 206872-001 Dec 6, 2016 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Amneal Pharms ENTECAVIR entecavir TABLET;ORAL 206652-002 Nov 12, 2015 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Par Pharm Inc ENTECAVIR entecavir TABLET;ORAL 206294-002 Nov 23, 2016 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Zydus Pharms Usa Inc ENTECAVIR entecavir TABLET;ORAL 206745-002 Jun 23, 2017 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Cipla Ltd ENTECAVIR entecavir TABLET;ORAL 206872-002 Dec 6, 2016 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Zydus Pharms Usa Inc ENTECAVIR entecavir TABLET;ORAL 206745-001 Jun 23, 2017 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Sandoz Inc ENTECAVIR entecavir TABLET;ORAL 206672-002 May 11, 2017 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Prinston Inc ENTECAVIR entecavir TABLET;ORAL 208782-002 Oct 10, 2017 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Julphar
AstraZeneca
Accenture
Baxter
Queensland Health
Boehringer Ingelheim
Harvard Business School
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot